Alembic Pharmaceuticals Share price target & analyst calls

₹787.95-2.40 (-0.30%)
As of 21 Oct 2026

Avg 1-year target

All 3 long-term calls are BUY

₹1,072.536.1% above today's price

Alembic Pharmaceuticals' average 1-year share price target is ₹1,072.5, the average of 2 advisors' latest targets. Targets range from ₹1,013 to ₹1,132.

Latest: BOB Capital Markets ₹1,013 · 16 May 2026

3
3 BUY · 0 SELL, all horizons
2
with an active 1Y target
N/A
8 of 10 closed calls needed
11
all horizons, open and closed

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Alembic Pharmaceuticals target price by brokerage

Each advisor's latest 1-year target · 2 advisors · tap a row for the call

All tips (11)

BUYTarget₹1,013
BCbyBOB Capital Markets+28.6% to target
1 Year* · 7 mo left · 16 May 2026 · entry ₹784.1 · via Institutional / Brokerage ResearchP&L +0.5%
BUYTarget₹1,132
1 Year* · 14d left · 5 Nov 2025 · entry ₹960.7 · via Institutional / Brokerage ResearchP&L -18.0%
BUYTarget₹1,136
BCbyBOB Capital Markets+44.2% to target
1 Year* · 14d left · 5 Nov 2025 · entry ₹960.7 · via Institutional / Brokerage ResearchP&L -18.0%
BUYTarget₹1,032
1 Year* · 12 Feb 2025 · entry ₹845.15 · via Institutional / Brokerage Researchexit ₹1,032
BUYTarget₹1,101
1 Year* · 6 Aug 2025 · entry ₹948.25 · via Institutional / Brokerage Researchexit ₹818.2
BUYTarget₹1,412
1 Year* · 7 Nov 2024 · entry ₹1,079.9 · via Institutional / Brokerage Researchexit ₹921.95
BUYTarget₹845
1–2 Weeks* · 4 Aug 2026 · entry ₹817.85 · via CNBC Awaaz.exit ₹845
BUYTarget₹845
1–2 Weeks* · 4 Aug 2026 · entry ₹805.75 · via CNBC Awaaz.exit ₹845
BUYTarget₹890
1–2 Weeks* · 18 Sept 2026 · entry ₹844.2 · via Zee Business (Live)exit ₹810
BUYTarget₹840
MJbyManas JaiswalStop-loss hit
1–2 Weeks* · 8 May 2026 · entry ₹794.75 · via CNBC Awaaz.exit ₹774
BUYTarget₹950
1–2 Weeks* · 23 Sept 2026 · entry ₹870 · via NDTV Profitexit ₹833.3

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks